The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of pembrolizumab for patients with previously treated advanced thymic epithelial tumor.
 
Jinhyun Cho
No Relationships to Disclose
 
Myung-Ju Ahn
No Relationships to Disclose
 
Kwai Han Yoo
No Relationships to Disclose
 
Hansang Lee
No Relationships to Disclose
 
Hee Kyung Kim
No Relationships to Disclose
 
Mi Hwa Heo
No Relationships to Disclose
 
Joo Hyun Hong
No Relationships to Disclose
 
Jong-Mu Sun
No Relationships to Disclose
 
Se-Hoon Lee
No Relationships to Disclose
 
Jin Seok Ahn
No Relationships to Disclose
 
Keunchil Park
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Hanmi; Kyowa Hakko Kirin; Lilly; Novartis; Ono Pharmaceutical; Roche
Speakers' Bureau - Boehringer Ingelheim
Research Funding - AstraZeneca